Tom Ransohoff has over 35 years of experience in the biopharmaceutical industry with broad and deep experience in the development and manufacture of biologic drugs and in the management of technology-based start-up firms. He is currently Principal, RTI Consulting, LLC, providing strategic and technical consulting services to firms in the life sciences field. Previously, Mr. Ransohoff was Technical Head, Biologics Franchise for National Resilience, Inc. who he joined through the acquisition of 4th Dimension Bioprocess (4D), where he was a co-founder and COO. Before co-founding 4D, Mr. Ransohoff was a Managing Director at BDO and its precursor BioProcess Technology Consultants (BPTC), a leading CMC consulting firm that he helped build over a 20 year period. Prior to that, he held senior level positions at TranXenoGen, Dyax, Repligen, and Xoma. Mr. Ransohoff is a co-founder of several successful start-ups in addition to 4D, including Tarpon Biosystems and BioFlash Partners. He holds a Bachelor’s degree from MIT and a Master’s degree from the University of California, Berkeley, both in Chemical Engineering.